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HORMONES AND AGING
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SUMMARY – Since the 19th century, there have been sporadic attempts to attribute the chan-
ges of aging to one or another endocrine deficit and efforts to reverse these changes by various repla-
cement therapies. This search for a hormonal ‘fountain of youth’ continues today.
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Aging is characterized by a progressive loss of co-
ordinated cell and tissue function, so that the body 
becomes gradually less fit to reproduce and survive. 
Deterioration of function is heterogeneous among 
individuals and is detectable first as a loss of reserve 
capacity and ability to restore homeostasis under 
stress, and later by altered function at rest. Strehler1 
has suggested five basic criteria best defining aging. 
It has a characteristic of accumulation, which means 
that the effect of aging increases over time. Also, it is 
universal, which implies that all members of a species 
are showing aging effect. Furthermore, it is intrinsic 
and alterations occur even when the individual is in 
optimal external life conditions. Aging is progressive, 
evolving a series of gradual changes. The last Strehler’s 
component is hurtfulness because normal function is 
compromised. Today, there are many theories trying 
to explain aging process but none has succeeded in 
providing complete answer to the question yet. Do 
hormones play a role in aging process, how large is 
their part and is there a possibility that hormones de-
fine the rhythm and speed of aging, is being widely 
considered, and the search for endocrine ‘fountain of 
youth’ is ongoing. Dilman2 and Dilman and Dean3 
have proposed a neuroendocrine theory of aging. The 
basic hypothesis of neuroendocrine theory advocates 
the central role of hypothalamus in aging while re-
duced sensitivity to hormones and other signaling 
peptides has been demonstrated at this level. This 
implies that aging could be regulated by hypothala-
mus and pituitary, which represent the body’s inter-
nal ‘pacemaker’ regulating physiological changes over 
time. To simplify, the loss of hypothalamic sensitivity 
leads to progressive loss of homeostasis, alterations in 
hormone concentrations, and reduction of neurotrans-
mitters and signaling molecules (Fig. 1). According to 
neuroendocrine theory, decreased sensitivity of hypo-
thalamus and peripheral receptors would cause energy 
misbalance, inadaptability, and weakening of immune 
and reproductive ability. The theory hypothesizes how 
metabolic changes, i.e. decreased glucose tolerance 
and hyperinsulinemia, hyperlipidemia, and especially 
HDL cholesterol reduction lead to gradual deteriora-
tion of health and death3. An example of the body 
decreased capacity of adjustment is cortisol activity. 
Decreased hypothalamic sensitivity causes weaken-
ing of negative feedback of cortisol in hypothalamus 
and pituitary, and progressively much greater concen-
trations of cortisol are needed to achieve suppression 
of corticotropin-releasing hormone (CRH) secretion 
from the hypothalamus and adrenocorticotropic hor-
mone (ACTH) secretion from the pituitary. Dilman 
proved this by measuring concentrations of cortisol 
in female patients of different age groups prior and 
following different surgical interventions. Results 
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showed much higher concentrations of plasma cortisol 
in older female patients after surgical procedures, al-
though prior to surgery there were no significant dif-
ferences in basal cortisol concentrations2. His results 
were confirmed in a study conducted by Mikhailovich 
et al.4, and they imply that people of older age have 
a more pronounced and prolonged reaction to stress 
than younger individuals. Previously mentioned alter-
ations in cortisol concentrations are often variable. It 
seems they have no immediate effect on the hypothal-
amus-pituitary-adrenal gland axis, but possibly exert a 
chronic clinically important influence. It appears they 
are associated with the lack of sleep in the elderly, re-
duced memory in women, osteoporosis in older men 
and an increased risk of fractures in both older men 
and women. The secretion rate and serum concentra-
tions of aldosterone fall with age and by about age 
70 the decreases can be as much as 50 percent. The 
proximate cause is a decrease in renin secretion. When 
marked (particularly in patients with renal failure), it 
can result in hypoaldosteronism, urinary sodium wast-
ing, hyponatremia and hyperkalemia5,6. Dehydroepi-
androsterone (DHEA) and dehydroepiandrosterone 
sulfate (DHEAS) are adrenal gland hormones that 
are precursors in the synthesis of active androgens and 
estrogens. Secretion of these steroids significantly de-
creases with age, so that in 70- to 80-year-old subjects 
serum concentrations of both are by about 20 percent 
of those in 20- to 30-year-old subjects. Whether this 
decrease has a true clinical meaning is still unknown. 
Many have speculated that DHEA administration 
might reverse some of the changes in body composi-
tion and behavior that occur with aging, but results of 
placebo-controlled trials in normal older subjects have 
revealed minimal benefit (small increases in bone den-
sity at some sites, small increases in muscle mass) and 
some harm (androgen effects in women and estrogen 
effects in men)7,8. In older people, serum norepineph-
rine concentrations are higher than in younger sub-
jects, whereas those of epinephrine are either the same 
or slightly lower. Norepinephrine levels appear to be 
a result of higher sympathetic nervous system activ-
ity, and not of the adrenal medulla. They are probably 
compensatory, due to the loss of responsiveness of at 
least some tissues to norepinephrine9-12. The volume 
of thyroid gland increases slightly with age. There are 
no age-related changes in serum total or free thyrox-
ine concentrations. Similarly, serum triiodothyronine 
Fig. 1. Neuroendocrine aging theory (from: Dilman V, Dean W. The neuroendocrine theory 
of aging. Pensacola: The Center for Bio-Gerontology, 1992)3.
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concentrations do not decrease with age significantly. 
Lower levels of triiodothyronine in some older sub-
jects are probably due to intercurrent nonthyroidal ill-
ness that reduces extrathyroidal conversion of thyrox-
ine to triiodothyronine. Serum parathyroid hormone 
(PTH) concentrations are slightly higher in older as 
compared with younger subjects. The most likely cause 
of this increase is a fall in serum calcium concentra-
tion due to mild vitamin D deficiency and phosphate 
retention caused by declining renal function.
The recognition that many older subjects have 
mild vitamin D deficiency, and the likelihood that it 
contributes to osteoporosis, falls and fractures in the 
elderly has led to the recommendation that subjects 
more than 70 years old should have a dietary vita-
min D intake of 800-1000 IU per day. The recom-
mended calcium intake is 1500 mg elemental calcium 
daily15-17. Weakening of the immune system, energy 
misbalance and loss of adaptability are also connected 
to aging. According to Fabris et al.18, the interaction 
between neuroendocrine and immune systems exists 
at two separate levels. First one includes interaction of 
neuroendocrine system and thymus, whose hormones 
(proteins and peptides) participate in T-lymphocyte 
function, regulation and differentiation. Their levels 
are subject to decrease with age, diminishing the ef-
ficacy of defense system. The second level is at the pe-
riphery where neuroendocrine signals affect excretion 
of cell mediators from immune cells (Fig. 2). Decreased 
reproductive ability is one of the aging components. 
Neuroendocrine component is crucial for decrement 
of reproductive ability, and the only endocrine system 
for which there is a well-defined, abrupt and univer-
sal change in function with age is the hypothalamic-
pituitary-gonadal axis in women (i.e. menopause)19. 
Wiese et al.20 propose that changes in suprachias-
matic nucleus (Fig. 3) influence cyclic alterations of 
reproductive function. Granulousa cells are produc-
ing less inhibin A and B after age 40, which leads to 
gradual but progressive growth of follicle-stimulating 
hormone (FSH) level, while the level of luteinizing 
hormone (LH) stays unchanged for a few more years. 
Increased levels of FSH stimulate follicular growth, 
but ovulation is seldom occurring. Follicles are pro-
ducing higher concentrations of estradiol (E2), but the 
level of progesterone is increasingly lower. The new 
relations of estrogen, progesterone and androgen con-
centrations are affecting the central nervous system 
Fig. 2. Thymus involution during the aging process (from: Fabris N, Mocchegiani E, Provinciali 
M. Plasticity of neuro-endocrine-thymus interactions during aging. Exp Gerontol 1997)18.
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and lead to as yet uninvestigated psycho-neuro-en-
docrinological syndromes, where the brain and ovary 
play the main role (Fig. 3). The total testosterone level 
gradually decreases, but as serum sex hormone-bind-
ing globulin concentrations increase with age, older 
men have a greater decline in serum free testosterone 
concentrations. This decline is sometimes referred to 
as ‘andropause’. However, unlike menopause, where 
complete estrogen deficiency with known clinical 
consequences occurs, the decline in androgens in ag-
ing men varies from modest to severe and has unclear 
clinical consequences. It is of note that more than 70 
percent of men over 70 years of age have free T lev-
els consistent with hypogonadism. Spermatogenesis is 
stable until the age of 70, when it starts to diminish. It 
is accompanied by tubular fibrosis, testicular shrink-
age and modest elevations of FSH21,22. Numerous 
studies tried to answer the question whether hormone 
replacement therapy could slow down aging process. 
In 1889, C.E. Brown-Sequard mentioned that in the 
future negative effects of aging would not only be di-
minished by hormone replacement, but would lead to 
rejuvenation23. Since then, most studies have investi-
gated the role of growth hormone in such a context, 
as it was noticed to influence body composition. Rud-
man et al.24,25 established that healthy men aged over 
65 have low levels of plasma IGF-1. It was also noticed 
that GH replacement significantly increases lean body 
mass and bone density, while at the same time de-
creasing body fat and LDL cholesterol levels. Baum et 
al.26 conclude that replacement therapy in the elderly 
with growth hormone deficiency improves the results 
of intelligence tests, but has no overall beneficial ef-
fects on cognitive functions or quality of life. Arwert 
et al.27 showed by using functional MRI that 6-month 
growth hormone replacement therapy in older peo-
Fig. 3. Suprachiasmatic nucleus of hypothalamus (from: Wise PM, Cohen IR, Weiland NG, London ED. Aging alters the 
circadian rhythm of glucose utilization in the suprachiasmatic nucleus. Proc Natl Acad Sci U S A 1988)20.
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ple improved long-term and working memory, while 
Ramsey et al.28 conclude that the same treatment slows 
down deterioration of cognitive functions. Papadakis 
et al.29 claim that older people on substitution therapy 
have a considerably higher capacity of wound healing 
and higher accumulation of collagen in wound area. 
Furthermore, when growth hormone replacement is 
combined with testosterone in older men or estrogen 
in women, it increases bone density. However, many 
side effects of such treatment have been observed. 
They primarily include glucose intolerance and dia-
betes, and some also consider mitogenic effect. These 
side effects prompt the need for thoughtful selection 
of appropriate patient population for replacement GH 
therapy. Neuroendocrine theory is one of the theories 
that put the endocrine component in the center of ag-
ing process. It is not exclusive and can put additional 
explanation into other theories. The accuracy of all 
theories will be evaluated in the future, but it seems 
likely that hormones would play an important role in 
final clarification of the aging process30.
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Sažetak
HORMONI I STARENJE
V. Zjačić-Rotkvić, L. Kavur i M. Cigrovski-Berković
Još od 19. stoljeća bilo je sporadičnih pokušaja da se promjene u starenju pripišu nekom endokrinom deficitu, kao i 
nastojanja da se utječe na te promjene različitim nadomjesnim terapijama. Ta potraga za hormonskim ‘izvorom mladosti’ 
traje do današnjih dana. 
Ključne riječi: starenje, endokrine žlijezde, proizvodnja hormona, hormonske nadomjesne tearpije
